Cochrane’s Governing Board is pleased to announce, effective 1 June 2021, the appointment of Judith Brodie as our new interim Chief Executive Officer. Judith will lead Cochrane as the organisation undergoes its search for a permanent CEO and in order to ensure a smooth transition.
She will work alongside the Governing Board and the Senior Management Team, and she will join forthcoming Governance Meetings on 22 and 24 June. Governing Board Co- Chairs Tracey Howe and Catherine Marshall welcomed Judith’s appointment: “Judith is a seasoned, well-respected, and proven interim Chief Executive with an exceptional record in nonprofit organisations and brings expertise in finance, fundraising, and public and patient involvement in healthcare and marketing. Judith is a great fit for Cochrane and is well qualified to lead Cochrane as we drive a programme of change at this crucial time of global health and economic challenge.”
On her appointment, Judith said: “I am delighted to be joining Cochrane and to be part of this global collaboration. The work of Cochrane has surely never been more important. I am looking forward to meeting and working with many of Cochrane Group’s staff and contributors and the wider network over the coming months.”
On behalf of Cochrane Rehabilitation, we warmly welcome Judith to this important leadership role.